Tag Archives: Bristol-Meyers Squibb

Bristol-Myers Squibb's Summertime Blues

By Ben Comer | Published: August 7, 2012
The sun was shining, savory scents were floating out from the grill, the lemonade was mixed and the table was set. But then dark clouds blew in and settled overhead. Bristol-Myers Squibb’s (BMS) picnic got rained out this summer. One element of the rain out was forecasted long ago; Plavix, the multibillion dollar [...]
Posted in Advertising, Biotech, Deals, FDA, Legal, Marketing, R&D, Regulatory, Safety, Sales, Strategy, compliance, pricing | Also tagged , , , , | Leave a comment

Icahn to BMS: Offer is Inadequate

By George Koroneos | Published: September 10, 2008
In a statement to the press today, ImClone Chairman Carl Icahn said that the review committee overlooking Bristol-Myers Squibb’s offer to purchase the biotech company for $60 per share $4.5 billion just isn’t good enough. He not only accused BMS of lowballing, but also admitted that the company has been in talks with the head of [...]
Posted in Biotech, Deals, Strategy | Also tagged , , , , , , , | 1 Comment